These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29661785)

  • 1. The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis.
    Verhelst J; Mattsson AF; Camacho-Hübner C; Luger A; Abs R
    Endocr Connect; 2018 May; 7(5):653-662. PubMed ID: 29661785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.
    Verhelst J; Mattsson AF; Luger A; Thunander M; Góth MI; Koltowska-Häggström M; Abs R
    Eur J Endocrinol; 2011 Dec; 165(6):881-9. PubMed ID: 21969523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.
    Attanasio AF; Mo D; Erfurth EM; Tan M; Ho KY; Kleinberg D; Zimmermann AG; Chanson P;
    J Clin Endocrinol Metab; 2010 Jan; 95(1):74-81. PubMed ID: 19897679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
    Kelestimur F; Jonsson P; Molvalilar S; Gomez JM; Auernhammer CJ; Colak R; Koltowska-Häggström M; Goth MI
    Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
    Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
    Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
    Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.
    Abs R; Mattsson AF; Thunander M; Verhelst J; Góth MI; Wilton P; Kołtowska-Häggström M; Luger A
    Eur J Endocrinol; 2013 Mar; 168(3):297-305. PubMed ID: 23211573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
    Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
    Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
    Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.
    Feldt-Rasmussen U; Abs R; Bengtsson BA; Bennmarker H; Bramnert M; Hernberg-Ståhl E; Monson JP; Westberg B; Wilton P; Wüster C;
    Eur J Endocrinol; 2002 Jan; 146(1):67-74. PubMed ID: 11751070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
    Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
    Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency.
    Schneider HJ; Klotsche J; Wittchen HU; Stalla GK; Schopohl J; Kann PH; Kreitschmann-Andermahr I; Wallaschofski H;
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):825-30. PubMed ID: 21658091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study.
    Casanueva FF; Leal A; Koltowska-Häggström M; Jonsson P; Góth MI
    Arch Phys Med Rehabil; 2005 Mar; 86(3):463-8. PubMed ID: 15759229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.
    Hoybye C; Jönsson P; Monson JP; Koltowska-Häggström M; Hána V; Geffner M; Abs R
    Eur J Endocrinol; 2007 Nov; 157(5):589-96. PubMed ID: 17984238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis.
    Klose M; Jonsson B; Abs R; Popovic V; Koltowska-Häggström M; Saller B; Feldt-Rasmussen U; Kourides I
    Eur J Endocrinol; 2009 Nov; 161 Suppl 1():S75-83. PubMed ID: 19684053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.
    Kendall-Taylor P; Jönsson PJ; Abs R; Erfurth EM; Koltowska-Häggström M; Price DA; Verhelst J
    Eur J Endocrinol; 2005 Apr; 152(4):557-67. PubMed ID: 15817911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.